
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Iguratimod ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the EMT process and NLRP3 inflammasome activation
Wenping Liu, Xiao Han, Qing Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113460-113460
Open Access | Times Cited: 46
Wenping Liu, Xiao Han, Qing Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113460-113460
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
The role of inflammasomes in human diseases and their potential as therapeutic targets
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 62
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 62
Comprehensive review of potential drugs with anti-pulmonary fibrosis properties
Jie Ma, Gang Li, Han Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116282-116282
Open Access | Times Cited: 18
Jie Ma, Gang Li, Han Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116282-116282
Open Access | Times Cited: 18
HMGB1 mediates epithelial-mesenchymal transition and fibrosis in silicosis via RAGE/β-catenin signaling
Lingli Guo, Lu Han, Jing Zhang, et al.
Chemico-Biological Interactions (2025), pp. 111385-111385
Closed Access | Times Cited: 2
Lingli Guo, Lu Han, Jing Zhang, et al.
Chemico-Biological Interactions (2025), pp. 111385-111385
Closed Access | Times Cited: 2
Divergent functions of NLRP3 inflammasomes in cancer: a review
Alireza Shadab, Mohamad Mahjoor, Mohammad Abbasi‐Kolli, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 34
Alireza Shadab, Mohamad Mahjoor, Mohammad Abbasi‐Kolli, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 34
Epithelial–mesenchymal plasticity in kidney fibrosis
Sudarat Hadpech, Visith Thongboonkerd
genesis (2023) Vol. 62, Iss. 1
Closed Access | Times Cited: 31
Sudarat Hadpech, Visith Thongboonkerd
genesis (2023) Vol. 62, Iss. 1
Closed Access | Times Cited: 31
The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review
Bowen Zhou, Huaman Liu, Fei Xu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Bowen Zhou, Huaman Liu, Fei Xu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Phosphorylation of FOXN3 by NEK6 promotes pulmonary fibrosis through Smad signaling
Jiuwei Yu, Yingke Li, Yi‐Ming Li, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Jiuwei Yu, Yingke Li, Yi‐Ming Li, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Regulation of alveolar macrophage death in pulmonary fibrosis: a review
Ganghao Yang, Yang Yang, Yiping Liu, et al.
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1505-1519
Open Access | Times Cited: 17
Ganghao Yang, Yang Yang, Yiping Liu, et al.
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1505-1519
Open Access | Times Cited: 17
Mirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model
Rasha Abdelhady, Simona Cavalu, Sameh Saber, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114553-114553
Open Access | Times Cited: 13
Rasha Abdelhady, Simona Cavalu, Sameh Saber, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114553-114553
Open Access | Times Cited: 13
Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway
Jiang Li, Qian Wei, Ke Song, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Jiang Li, Qian Wei, Ke Song, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Mechanisms of Bleomycin-induced Lung Fibrosis: A Review of Therapeutic Targets and Approaches
Shaimaa M. Mohammed, Haider Falih Shamikh Al-Saedi, Amjed Qasim Mohammed, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1845-1870
Closed Access | Times Cited: 4
Shaimaa M. Mohammed, Haider Falih Shamikh Al-Saedi, Amjed Qasim Mohammed, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1845-1870
Closed Access | Times Cited: 4
Anti-Fibrotic Effects of Saengmaek-San, a Prescription of Traditional Korean Medicine in Bleomycin-Induced Pulmonary Fibrosis Mice Model
Donghyun Lee, Jeong-Won Shin, Eui-Joong Kim, et al.
(2025)
Closed Access
Donghyun Lee, Jeong-Won Shin, Eui-Joong Kim, et al.
(2025)
Closed Access
Iguratimod improves bleomycin-induced pulmonary inflammation and fibrosis by regulating macrophage polarization through inhibiting the TLR4/NF-κB pathway
Huan Xu, Koval' Ma, Z. Ma, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Huan Xu, Koval' Ma, Z. Ma, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Zinc finger and broad-complex, tramtrack, and bric-a-brac domain containing 16 silencing attenuates bleomycin-induced pulmonary fibrosis in mice through inhibition of the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin pathway
Xiansong Fang, Xiaoyun Wen, Liang Zhou, et al.
CytoJournal (2025) Vol. 22, pp. 37-37
Open Access
Xiansong Fang, Xiaoyun Wen, Liang Zhou, et al.
CytoJournal (2025) Vol. 22, pp. 37-37
Open Access
The effective-compound compatibility of JHF inhibits fibroblast activation in pulmonary fibrosis by enhancing PINK1/PARK2-mediated mitophagy
Yunping Bai, Xiaohong Yin, Qin Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Yunping Bai, Xiaohong Yin, Qin Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Mechanical stress overload promotes NF-κB/NLRP3-mediated osteoarthritis synovitis and fibrosis through Piezo1
Likai Yu, Tian Di, Z. Su, et al.
Cellular Signalling (2025), pp. 111786-111786
Closed Access
Likai Yu, Tian Di, Z. Su, et al.
Cellular Signalling (2025), pp. 111786-111786
Closed Access
AnxA2-EGFR pro-inflammatory signaling potentiates EMT-induced fibrotic stress and its modulation by short-chain fatty acid butyrate in idiopathic pulmonary fibrosis
Vinay C. Sangamesh, Pavan K. Jayaswamy, M. Vijaykrishnaraj, et al.
Toxicology and Applied Pharmacology (2025), pp. 117342-117342
Closed Access
Vinay C. Sangamesh, Pavan K. Jayaswamy, M. Vijaykrishnaraj, et al.
Toxicology and Applied Pharmacology (2025), pp. 117342-117342
Closed Access
Gui-zhi-fu-ling-wan alleviates bleomycin-induced pulmonary fibrosis through inhibiting epithelial-mesenchymal transition and ferroptosis
Z. Chen, Mengmeng Ma, Rui Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Z. Chen, Mengmeng Ma, Rui Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Combination Treatment of Timosaponin BII and Pirfenidone Attenuated Pulmonary Fibrosis Through Anti-Inflammatory and Anti-Fibrotic Process in Rodent Pulmonary Fibrosis Model and Cellular Epithelial–Mesenchymal Transition Model
Xuebin Shen, Yueyue Zheng, Hui Yang, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1821-1821
Open Access
Xuebin Shen, Yueyue Zheng, Hui Yang, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1821-1821
Open Access
Mechanism of Astragalus Polysaccharide in Alleviating Bovine Mammary Fibrosis Through ROS/NLRP3 Inhibition and EMT Regulation
Jiang Zhang, Kejiang Liu, Tingji Yang, et al.
Antioxidants (2025) Vol. 14, Iss. 5, pp. 503-503
Open Access
Jiang Zhang, Kejiang Liu, Tingji Yang, et al.
Antioxidants (2025) Vol. 14, Iss. 5, pp. 503-503
Open Access
Iguratimod alleviated Sjögren's syndrome through regulating macrophage polarization
Junqiao Guo, Yu Chen, Shumin Wang, et al.
Rheumatology & autoimmunity (2025)
Open Access
Junqiao Guo, Yu Chen, Shumin Wang, et al.
Rheumatology & autoimmunity (2025)
Open Access
Iguratimod prevents renal fibrosis in unilateral ureteral obstruction model mice by suppressing M2 macrophage infiltration and macrophage–myofibroblast transition
Yueyuan Zhou, Zhilan Li, Shenyi Yu, et al.
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 3
Yueyuan Zhou, Zhilan Li, Shenyi Yu, et al.
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 3
LPS-induced monocarboxylate transporter-1 inhibition facilitates lactate accumulation triggering epithelial-mesenchymal transformation and pulmonary fibrosis
Jinhua Feng, Han Zhong, Shuya Mei, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Jinhua Feng, Han Zhong, Shuya Mei, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Harmine inhibits pulmonary fibrosis through regulating DNA damage repair-related genes and activation of TP53-Gadd45α pathway
Yuehong Gong, Jie Wang, Meichi Pan, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112542-112542
Closed Access | Times Cited: 3
Yuehong Gong, Jie Wang, Meichi Pan, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112542-112542
Closed Access | Times Cited: 3
Inflammation unleashed: The role of pyroptosis in chronic liver diseases
Lujian Zhu, Hongjie Tong, Chao Ren, et al.
International Immunopharmacology (2024) Vol. 141, pp. 113006-113006
Open Access | Times Cited: 3
Lujian Zhu, Hongjie Tong, Chao Ren, et al.
International Immunopharmacology (2024) Vol. 141, pp. 113006-113006
Open Access | Times Cited: 3